On the relevance of an in vitro reconstructed human epidermis model for drug screening in atopic dermatitis

3D skin models for 3R research: The potential of 3D reconstructed skin models to study skin barrier function

(2018) Hanna Niehues et al.   EXPERIMENTAL DERMATOLOGY

Primary Role of Barrier Dysfunction in the Pathogenesis of Atopic Dermatitis

(2018) Peter M. Elias   EXPERIMENTAL DERMATOLOGY

Alternatives to animal testing in basic and preclinical research of atopic dermatitis

(2018) Anna Löwa et al.   EXPERIMENTAL DERMATOLOGY

Reconstructed human epidermis for in vitro studies on atopic dermatitis: A review

(2018) F. Huet et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

A molecular mechanism for IL-4 suppression of loricrin transcription in epidermal keratinocytes: implication for atopic dermatitis pathogenesis

(2017) Lei Bao et al.   Innate Immunity

Atopic dermatitis: the new frontier

(2017) Victoria R Harris et al.   MEDICAL JOURNAL OF AUSTRALIA

Methyl-β-cyclodextrin concurs with interleukin (IL)-4, IL-13 and IL-25 to induce alterations reminiscent of atopic dermatitis in reconstructed human epidermis

(2016) Évelyne De Vuyst et al.   EXPERIMENTAL DERMATOLOGY

Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march

(2016) Gyohei Egawa et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

STAT6 and PARP Family Members in the Development of T Cell-dependent Allergic Inflammation

(2016) Purna Krishnamurthy et al.   Immune Network

Skin Concentrations of Topically Applied Substances in Reconstructed Human Epidermis (RHE) Compared with Human Skin Using in vivo Confocal Raman Microscopy

(2015) Franziska D. Fleischli et al.   CHIMIA

The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling

(2015) Wataru Amano et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Hyaluronan Metabolism in Human Keratinocytes and Atopic Dermatitis Skin Is Driven by a Balance of Hyaluronan Synthases 1 and 3

(2014) Jérémy Malaisse et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

IL-4 regulates chemokine CCL26 in keratinocytes through the Jak1, 2/Stat6 signal transduction pathway: Implication for atopic dermatitis

(2012) Lei Bao et al.   MOLECULAR IMMUNOLOGY

IL-4 Regulates Skin Homeostasis and the Predisposition toward Allergic Skin Inflammation

(2010) S. Sehra et al.   JOURNAL OF IMMUNOLOGY

A Novel STAT6 Inhibitor AS1517499 Ameliorates Antigen-Induced Bronchial Hypercontractility in Mice

(2009) Yoshihiko Chiba et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Murine atopic dermatitis responds to peroxisome proliferator-activated receptors α and β/δ (but not γ) and liver X receptor activators

(2009) Yutaka Hatano et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6

(2008) Byung Eui Kim et al.   CLINICAL IMMUNOLOGY

Thematic Review Series: Skin Lipids.Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology

(2008) Matthias Schmuth et al.   JOURNAL OF LIPID RESEARCH